Amgen 2011 Annual Report Download - page 114

Download and view the complete annual report

Please find page 114 of the 2011 Amgen annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 184

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184

Exhibit No. Description
4.7 Officer’s Certificate, dated as of January 1, 1992, as supplemented by the First Supplemental
Indenture, dated as of February 26, 1997, establishing a series of securities entitled “8 1/8%
Debentures due April 1, 2097.” (Filed as an exhibit to Form 8-K filed on April 8, 1997 and
incorporated herein by reference.)
4.8 Form of Liquid Yield Option™ Note due 2032. (Filed as an exhibit to Form 8-K on March 1, 2002
and incorporated herein by reference.)
4.9 Indenture, dated as of March 1, 2002. (Filed as an exhibit to Form 8-K on March 1, 2002 and
incorporated herein by reference.)
4.10 First Supplemental Indenture, dated March 2, 2005. (Filed as an exhibit to Form 8-K filed on
March 4, 2005 and incorporated herein by reference.)
4.11 Indenture, dated as of August 4, 2003. (Filed as an exhibit to Form S-3 Registration Statement on
August 4, 2003 and incorporated herein by reference.)
4.12 Form of 4.85% Senior Notes due 2014. (Filed as an exhibit to Form 8-K on November 19, 2004
and incorporated herein by reference.)
4.13 Officers’ Certificate, dated November 18, 2004, including forms of the 4.00% Senior Notes due
2009 and 4.85% Senior Notes due 2014. (Filed as an exhibit to Form 8-K on November 19, 2004
and incorporated herein by reference.)
4.14 Form of Zero Coupon Convertible Note due 2032. (Filed as an exhibit to Form 8-K on May 6,
2005 and incorporated herein by reference.)
4.15 Indenture, dated as of May 6, 2005. (Filed as an exhibit to Form 8-K on May 6, 2005 and
incorporated herein by reference.)
4.16 Indenture, dated as of February 17, 2006 and First Supplemental Indenture, dated as of June 8,
2006 (including form of 0.375% Convertible Senior Note due 2013). (Filed as exhibit to Form 10-
Q for the quarter ended June 30, 2006 on August 9, 2006 and incorporated herein by reference.)
4.17 Corporate Commercial Paper - Master Note between and among Amgen Inc., as Issuer, Cede &
Co., as Nominee of The Depository Trust Company, and Citibank, N.A., as Paying Agent. (Filed
as an exhibit to Form 10-Q for the quarter ended March 31, 1998 on May 13, 1998 and
incorporated herein by reference.)
4.18 Officers’ Certificate of Amgen Inc. dated as of May 30, 2007, including forms of the Company’s
Senior Floating Rate Notes due 2008, 5.85% Senior Notes due 2017 and 6.375% Senior Notes due
2037. (Filed as an exhibit to Form 8-K on May 30, 2007 and incorporated herein by reference.)
4.19 Officers’ Certificate of Amgen Inc. dated as of May 23, 2008, including forms of the Company’s
6.15% Senior Notes due 2018 and 6.90% Senior Notes due 2038. (Filed as exhibit to Form 8-K on
May 23, 2009 and incorporated herein by reference.)
4.20 Officers’ Certificate of Amgen Inc. dated as of January 16, 2009, including forms of the
Company’s 5.70% Senior Notes due 2019 and 6.40% Senior Notes due 2039. (Filed as exhibit to
Form 8-K on January 16, 2009 and incorporated herein by reference.)
4.21 Officers’ Certificate of Amgen Inc. dated as of March 12, 2010, including forms of the Company’s
4.50% Senior Notes due 2020 and 5.75% Senior Notes due 2040. (Filed as exhibit to Form 8-K on
March 15, 2010 and incorporated herein by reference.)
4.22 Officers’ Certificate of Amgen Inc., dated as of September 16, 2010, including forms of the
Company’s 3.45% Senior Notes due 2020 and 4.95% Senior Notes due 2041. (Filed as an exhibit
to Form 8-K on September 17, 2010 and incorporated herein by reference.)
98